info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Siponimod (Mayzent)
513
Article source: Seagull Pharmacy
Oct 30, 2025

Siponimod (Mayzent) is a sphingosine 1-phosphate (S1P) receptor modulator used for the treatment of relapsing forms of multiple sclerosis (MS).

Indications for Siponimod (Mayzent)

Primary Indications

Siponimod is indicated for the treatment of adult patients with the following relapsing forms of multiple sclerosis (MS).

Clinically Isolated Syndrome (CIS): For patients who experience a first demyelinating event and are at high risk of relapse.

Relapsing-Remitting Multiple Sclerosis (RRMS): For reducing the frequency of disease relapses and delaying the progression of disability.

Active Secondary Progressive Multiple Sclerosis (aSPMS): For patients with secondary progressive disease who have evidence of disease activity (such as relapses or MRI lesions).

Dosage Forms, Strengths and Properties of Siponimod (Mayzent)

Dosage Forms and Strengths

0.25mg tablets: Light red, round, biconvex film-coated tablets with beveled edges. One side is engraved with "T", and the other side is blank.

1mg tablets: Purple-white, round, biconvex film-coated tablets with beveled edges. One side is engraved with "L", and the other side is blank.

2mg tablets: Light yellow, round, biconvex film-coated tablets with beveled edges. One side is engraved with "II", and the other side is blank.

Excipient Ingredients

The tablet core contains microcrystalline cellulose, crospovidone, etc.

The film coating contains polyvinyl alcohol, titanium dioxide, and iron oxide colorants (red and black iron oxides for 0.25mg and 1mg tablets; red and yellow iron oxides for 2mg tablets), etc.

Administration Method

Swallow the tablet whole. Do not split, crush, or chew it.

A 5-day dose escalation (starting at 0.25mg/day and gradually increasing to 2mg/day) is required to reduce the risk of cardiac adverse reactions.

Storage Methods for Siponimod (Mayzent)

Unopened Packaging

Store under refrigeration at 2°C–8°C (36°F–46°F).

After being dispensed to patients by the pharmacy, it can be stored at room temperature (20°C–25°C / 68°F–77°F) for a maximum of 3 months.

Opened Packaging

Bottled tablets: After opening, they can be stored at room temperature for 3 months, no refrigeration required.

Initiation pack (blister cards): After opening, the original calendarized blister packaging must be retained, and the product should be stored at room temperature for no more than 3 months.

Precautions

Avoid direct sunlight and humid environments.

Keep out of the reach of children.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase Siponimod (Mayzent)
Siponimod (Mayzent) is a sphingosine 1-phosphate (S1P) receptor modulator used for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relaps...
What Are the Side Effects of Fedratinib (Inrebic)?
Fedratinib (Inrebic) is a kinase inhibitor used for the treatment of adult patients with intermediate-2 or high-risk primary myelofibrosis (MF), or myelofibrosis secondary to polycythemia vera or esse...
Precautions for Fedratinib (Inrebic) Administration
Fedratinib (Inrebic) is a kinase inhibitor. It is indicated for the treatment of adult patients with intermediate-2 or high-risk primary myelofibrosis, or myelofibrosis secondary to polycythemia vera/...
How to Use Fedratinib (Inrebic)
Fedratinib (Inrebic) is a kinase inhibitor. It is indicated for the treatment of adult patients with intermediate-2 or high-risk primary myelofibrosis, or myelofibrosis secondary to polycythemia vera ...
How to Use Siponimod (Mayzent)
Siponimod (Mayzent) is a sphingosine 1-phosphate (S1P) receptor modulator used for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relaps...
Precautions for Administration of Isavuconazonium Sulfate Capsules (Cresemba)
Isavuconazonium Sulfate Capsules (Cresemba) are a triazole antifungal agent primarily indicated for the treatment of invasive aspergillosis and mucormycosis.Precautions for Administration of Isavucona...
How to Purchase Clofazimine
Clofazimine is a prescription medication used for the treatment of leprosy and certain mycobacterial infections. Due to its specific uses and pharmacological properties, its purchase must strictly com...
Indications for Clofazimine
Clofazimine is an antimycobacterial agent. Since its approval in the United States in 1986, it has been mainly used for the treatment of leprosy and its complications.Indications for ClofazimineTreatm...
Related Articles
Contraindications and Special Populations of Brensocatib Tablets
The prescribing information for Brixocatib tablets indicates that there are no absolute contraindications, but careful assessment of risks and benefits is still required in patients with special physi...
Dosage and Administration of Isatuximab Injection (Sarclisa)
Sarclisa must be administered under the supervision of a healthcare professional, and the administration site must be equipped with immediately available emergency equipment and medical support to man...
Indications and Dosage of Tepotinib
Tepotinib is an oral MET tyrosine kinase inhibitor indicated for the treatment of non-small cell lung cancer harboring MET exon 14 skipping mutations.I. Indications and Patient Selection1. Applicable ...
Dosage and Administration of Zidesamtinib
Before the first administration of Ziditnib, the following baseline assessments must be completed: serum creatine phosphokinase level, electrocardiogram, blood electrolytes (potassium, magnesium, calc...
Indications and Dosage and Administration of Ripretinib
Ripretinib is a kinase inhibitor specifically indicated for adult patients with advanced gastrointestinal stromal tumors who have previously received three or more kinase inhibitors.I. Indications and...
Contraindications and Medication in Special Populations of Ripretinib
Ripretinib does not list any absolute contraindications in its prescribing information, but there are clear usage restrictions or risks for specific physiological states and populations.I. Clear Contr...
Adverse Reactions of Ripretinib
Unlike traditional inhibition that targets the active site of a single kinase, ripretinib modulates the kinase "switch" conformation to suppress aberrant kinase signaling of KIT and PDGFRA, ...
Contraindications and Medication in Special Populations of Etoricoxib
Etoricoxib is effective for pain relief, but due to its cardiovascular and gastrointestinal risks, there are clear contraindications for its use.I. Absolute contraindications: who must not use it1. Al...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved